David James Bright

Background

About David James Bright

David focuses on complex commercial, shareholder, and contract disputes, and has significant experience in white collar defense and corporate governance. His clients span various industries with a focus on the cannabis, cryptocurrency, media, and technology space, and include public and private companies, private equity groups, sellers of large assets, and individuals including board members, company executives, and brokers/dealers. David also enjoys a diverse, multidisciplinary academic and professional background that includes a bachelor’s degree in political science from Harvard University, a J.D. from Columbia Law School, and an M.B.A. from Trinity College Dublin where he graduated at the top of his class. His representative matters include: • Counsel for seller in $200M+ merger & acquisition of a crypto mining facility • Counsel for shareholder of a $400M+ cannabis conglomerate in a hostile squeeze-out • Counsel for CEO of a renewable energy company in a SEC investigation alleging securities fraud • Represented Creditor’s Committee in the ~$2B bankruptcy of a major retailer • Counsel for founders of a media advertising firm in connection with a $20M disputed earn-out • Counsel for several manufacturers and retailers in various class actions involving product liability, etc • Counsel for shareholders in multiple disputes over celebrity-owned cannabis companies • Counsel for leading cannabis companies in complex trade secret disputes (cannabis strains, extraction methods, etc) • Represented Fortune 500 media conglomerate in an antitrust suit alleging the unlawful tying of channel licensing • Represented D & Os of a major tech. company in breach of fiduciary duty action concerning a $425M+ acquisition • Counsel for the D & Os of two international tech. companies in their defense of a toxic shareholder derivative action • Counsel for RMBS trader from a major multinational investment bank in a SEC investigation alleging securities fraud • Represented a Fortune 200 pharmaceutical company facing multiple allegations of FCPA, fraud, corruption, and bribery violations in China, Europe, and South America • Counsel for Fortune 200 multinational investment bank against investigations and inquiries from various financial regulators (e.g. FINRA, CFTC, etc). • Counsel for Liquidation Trustee in its $40M+ adversary proceeding against regional telcom provider